Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Dose-finding study of DG-031 on inflammatory biomarkers in patients with prior myocardial infarction
2005-002145-39Phase 2Completed
- Sponsor
- deCODE genetics ehf.
- Start
- May 2005
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of veliflapon in coronary arteriosclerosis, myocardial infarction (MI), sponsored by deCODE genetics ehf.. Started May 2005; status: completed.
02
Drugs
veliflapon
03
Conditions
coronary arteriosclerosismyocardial infarction (MI)
Beyond the preview
Go deeper on 2005-002145-39.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2005-002145-39.